Supernus Pharmaceuticals Reports Q2 2026 Results: Full Earnings Call Transcript

Article summary

Supernus Pharmaceuticals (NASDAQ:SUPN) held its second-quarter earnings conference call on Tuesday. Below is the complete transcript from the call. This transcript is brought to you by Benzinga APIs. For real-time